
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Potent Fc Receptor Signaling by IgA Leads to Superior Killing of Cancer Cells by Neutrophils Compared to IgG
Arianne M. Brandsma, Sina Bondza, Mitchell Evers, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 115
Arianne M. Brandsma, Sina Bondza, Mitchell Evers, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 115
Showing 1-25 of 115 citing articles:
Neutrophil diversity and plasticity in tumour progression and therapy
Sébastien Jaillon, Andrea Ponzetta, Diletta Di Mitri, et al.
Nature reviews. Cancer (2020) Vol. 20, Iss. 9, pp. 485-503
Closed Access | Times Cited: 836
Sébastien Jaillon, Andrea Ponzetta, Diletta Di Mitri, et al.
Nature reviews. Cancer (2020) Vol. 20, Iss. 9, pp. 485-503
Closed Access | Times Cited: 836
Neutrophils in cancer carcinogenesis and metastasis
Shu-Min Xiong, Liaoliao Dong, Lin Cheng
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 331
Shu-Min Xiong, Liaoliao Dong, Lin Cheng
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 331
Immunosuppressive cells in cancer: mechanisms and potential therapeutic targets
Yan Tie, Fan Tang, Yuquan Wei, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 279
Yan Tie, Fan Tang, Yuquan Wei, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 279
IgA: Structure, Function, and Developability
Patrícia de Sousa-Pereira, Jenny M. Woof
Antibodies (2019) Vol. 8, Iss. 4, pp. 57-57
Open Access | Times Cited: 185
Patrícia de Sousa-Pereira, Jenny M. Woof
Antibodies (2019) Vol. 8, Iss. 4, pp. 57-57
Open Access | Times Cited: 185
Tumor-associated myeloid cells: diversity and therapeutic targeting
Alberto Mantovani, Federica Marchesi, Sébastien Jaillon, et al.
Cellular and Molecular Immunology (2021) Vol. 18, Iss. 3, pp. 566-578
Open Access | Times Cited: 148
Alberto Mantovani, Federica Marchesi, Sébastien Jaillon, et al.
Cellular and Molecular Immunology (2021) Vol. 18, Iss. 3, pp. 566-578
Open Access | Times Cited: 148
Avidity in antibody effector functions and biotherapeutic drug design
Simone C. Oostindie, Greg A. Lazar, Janine Schuurman, et al.
Nature Reviews Drug Discovery (2022) Vol. 21, Iss. 10, pp. 715-735
Open Access | Times Cited: 139
Simone C. Oostindie, Greg A. Lazar, Janine Schuurman, et al.
Nature Reviews Drug Discovery (2022) Vol. 21, Iss. 10, pp. 715-735
Open Access | Times Cited: 139
Neutrophils at the Crossroads: Unraveling the Multifaceted Role in the Tumor Microenvironment
Deepika Awasthi, Aditya Sarode
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2929-2929
Open Access | Times Cited: 15
Deepika Awasthi, Aditya Sarode
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2929-2929
Open Access | Times Cited: 15
With great power, comes great responsibility: the importance of broadly measuring Fc-mediated effector function early in the antibody development process
Silvia Crescioli, Shashidhar S. Jatiani, Leonard Moise
mAbs (2025) Vol. 17, Iss. 1
Open Access | Times Cited: 2
Silvia Crescioli, Shashidhar S. Jatiani, Leonard Moise
mAbs (2025) Vol. 17, Iss. 1
Open Access | Times Cited: 2
Tumor-Associated Neutrophils in Hepatocellular Carcinoma Pathogenesis, Prognosis, and Therapy
Konstantinos Arvanitakis, Ioannis Mitroulis, Georgios Germanidis
Cancers (2021) Vol. 13, Iss. 12, pp. 2899-2899
Open Access | Times Cited: 84
Konstantinos Arvanitakis, Ioannis Mitroulis, Georgios Germanidis
Cancers (2021) Vol. 13, Iss. 12, pp. 2899-2899
Open Access | Times Cited: 84
Plasticity in Pro- and Anti-tumor Activity of Neutrophils: Shifting the Balance
Charita Furumaya, Paula Martínez-Sanz, Panagiota Bouti, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 81
Charita Furumaya, Paula Martínez-Sanz, Panagiota Bouti, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 81
Improving Antibody Therapeutics by Manipulating the Fc Domain: Immunological and Structural Considerations
George Delidakis, Jin Eyun Kim, Katia George, et al.
Annual Review of Biomedical Engineering (2022) Vol. 24, Iss. 1, pp. 249-274
Open Access | Times Cited: 47
George Delidakis, Jin Eyun Kim, Katia George, et al.
Annual Review of Biomedical Engineering (2022) Vol. 24, Iss. 1, pp. 249-274
Open Access | Times Cited: 47
Neutrophils and polymorphonuclear myeloid-derived suppressor cells: an emerging battleground in cancer therapy
Hans Raskov, Adile Orhan, Shruti Gaggar, et al.
Oncogenesis (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 44
Hans Raskov, Adile Orhan, Shruti Gaggar, et al.
Oncogenesis (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 44
Advances in IgA glycosylation and its correlation with diseases
Ding Li, Xiangqin Chen, Hongwei Cheng, et al.
Frontiers in Chemistry (2022) Vol. 10
Open Access | Times Cited: 39
Ding Li, Xiangqin Chen, Hongwei Cheng, et al.
Frontiers in Chemistry (2022) Vol. 10
Open Access | Times Cited: 39
The Role of Cytokines in Neutrophil Development, Tissue Homing, Function and Plasticity in Health and Disease
Maria Tsioumpekou, Daniëlle Krijgsman, Jeanette H.W. Leusen, et al.
Cells (2023) Vol. 12, Iss. 15, pp. 1981-1981
Open Access | Times Cited: 28
Maria Tsioumpekou, Daniëlle Krijgsman, Jeanette H.W. Leusen, et al.
Cells (2023) Vol. 12, Iss. 15, pp. 1981-1981
Open Access | Times Cited: 28
Therapeutic Monoclonal Antibodies against Cancer: Present and Future
Marisa Delgado, José A. García‐Sanz
Cells (2023) Vol. 12, Iss. 24, pp. 2837-2837
Open Access | Times Cited: 27
Marisa Delgado, José A. García‐Sanz
Cells (2023) Vol. 12, Iss. 24, pp. 2837-2837
Open Access | Times Cited: 27
Lupus IgA1 autoantibodies synergize with IgG to enhance plasmacytoid dendritic cell responses to RNA-containing immune complexes
Hayley R. Waterman, Matthew J. Dufort, Sylvia Posso, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 754
Open Access | Times Cited: 8
Hayley R. Waterman, Matthew J. Dufort, Sylvia Posso, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 754
Open Access | Times Cited: 8
Regulatory considerations in the design, development and quality of monoclonal antibodies and related products for the diagnosis and treatment of cancer
Marjorie A. Shapiro
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 7
Marjorie A. Shapiro
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 7
Genetic Variation in Low-To-Medium-Affinity Fcγ Receptors: Functional Consequences, Disease Associations, and Opportunities for Personalized Medicine
Sietse Q. Nagelkerke, David E. Schmidt, Masja de Haas, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 73
Sietse Q. Nagelkerke, David E. Schmidt, Masja de Haas, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 73
IgA-Mediated Killing of Tumor Cells by Neutrophils Is Enhanced by CD47–SIRPα Checkpoint Inhibition
Louise W. Treffers, Toine ten Broeke, Thies Rösner, et al.
Cancer Immunology Research (2019) Vol. 8, Iss. 1, pp. 120-130
Open Access | Times Cited: 68
Louise W. Treffers, Toine ten Broeke, Thies Rösner, et al.
Cancer Immunology Research (2019) Vol. 8, Iss. 1, pp. 120-130
Open Access | Times Cited: 68
The Basic Characteristics of the Pentraxin Family and Their Functions in Tumor Progression
Zeyu Wang, Xing Wang, Hecun Zou, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 54
Zeyu Wang, Xing Wang, Hecun Zou, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 54
Fc Engineering Strategies to Advance IgA Antibodies as Therapeutic Agents
Geert van Tetering, Mitchell Evers, Chilam Chan, et al.
Antibodies (2020) Vol. 9, Iss. 4, pp. 70-70
Open Access | Times Cited: 53
Geert van Tetering, Mitchell Evers, Chilam Chan, et al.
Antibodies (2020) Vol. 9, Iss. 4, pp. 70-70
Open Access | Times Cited: 53
Augmented antibody-based anticancer therapeutics boost neutrophil cytotoxicity
Niels Heemskerk, Mandy Gruijs, A. Robin Temming, et al.
Journal of Clinical Investigation (2021) Vol. 131, Iss. 6
Open Access | Times Cited: 43
Niels Heemskerk, Mandy Gruijs, A. Robin Temming, et al.
Journal of Clinical Investigation (2021) Vol. 131, Iss. 6
Open Access | Times Cited: 43
Albumin-hitchhiking: Fostering the pharmacokinetics and anticancer therapeutics
Paras Famta, Saurabh Shah, Naitik Jain, et al.
Journal of Controlled Release (2022) Vol. 353, pp. 166-185
Closed Access | Times Cited: 35
Paras Famta, Saurabh Shah, Naitik Jain, et al.
Journal of Controlled Release (2022) Vol. 353, pp. 166-185
Closed Access | Times Cited: 35
Neutrophils as immune effector cells in antibody therapy in cancer
Leonie M. Behrens, Marjolein van Egmond, Timo K. van den Berg
Immunological Reviews (2022) Vol. 314, Iss. 1, pp. 280-301
Open Access | Times Cited: 28
Leonie M. Behrens, Marjolein van Egmond, Timo K. van den Berg
Immunological Reviews (2022) Vol. 314, Iss. 1, pp. 280-301
Open Access | Times Cited: 28
IgA Complexes Induce Neutrophil Extracellular Trap Formation More Potently Than IgG Complexes
Anna-Katharina Gimpel, Antonio Maccataio, Harald Unterweger, et al.
Frontiers in Immunology (2022) Vol. 12
Open Access | Times Cited: 27
Anna-Katharina Gimpel, Antonio Maccataio, Harald Unterweger, et al.
Frontiers in Immunology (2022) Vol. 12
Open Access | Times Cited: 27